WOOF Petco Health & Wellness Company, Inc.
Retail-Retail Stores, NEC · Nasdaq · SEC CIK 1826470 · Fiscal year ends 01/30
Financial factors as of 2026-08-01 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-1.3%
TTM net income YoY207.3%
TTM EPS YoY200.0%
Revenue 3-yr CAGR-1.1%
Net income 3-yr CAGR-5.8%
Margins
Gross margin38.8%
Operating margin2.2%
Net margin0.5%
FCF margin4.0%
EBITDA margin5.5%
Returns
ROE2.6%
ROA0.6%
ROIC (approx.)6.6%
Asset turnover1.16x
Leverage & solvency
Liabilities / assets76.6%
Debt / equity0.50x
Current ratio0.90x
Interest coverage1.03x
Cash quality & payout
Operating cash flow / net income12.36x
Accruals ratio-6.7%
Payout ratio—
Capex / revenue2.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q22026-08-01 | 2026Q12026-05-02 | 2025Q4*2026-01-31 | 2025Q32025-11-01 | 2025Q22025-08-02 | 2025Q12025-05-03 | 2024Q4*2025-02-01 | 2024Q32024-11-02 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.49B | $1.50B | $1.52B | $1.46B | $1.49B | $1.49B | $1.55B | $1.51B |
| Cost of revenue | $898.07M | $922.31M | $934.36M | $895.40M | $903.21M | $923.43M | $962.87M | $935.68M |
| Gross profit | $591.15M | $574.42M | $580.77M | $569.01M | $585.32M | $569.97M | $589.26M | $575.76M |
| SG&A expense | $543.34M | $549.80M | $548.91M | $539.82M | $542.30M | $553.61M | $571.87M | $571.78M |
| Operating income | $47.81M | $24.63M | $31.86M | $29.20M | $43.02M | $16.36M | $17.39M | $3.98M |
| Interest expense | $32.56M | $32.78M | $31.58M | $32.83M | $33.30M | $33.49M | $34.11M | $35.80M |
| Pretax income | $17.75M | -$18.50M | $22.29M | -$1.82M | $10.63M | -$15.78M | -$16.45M | -$22.01M |
| Income tax | -$15.71M | $2.20M | $11.30M | -$6.28M | $746,000 | $495,000 | $2.50M | -$857,000 |
| Net income | $38.66M | -$15.15M | -$2.58M | $9.33M | $13.97M | -$11.66M | -$13.84M | -$16.67M |
| EBITDA | $98.21M | $73.67M | $80.10M | $79.01M | $92.38M | $66.17M | $67.70M | $54.09M |
| EPS (basic) | 0.14 | -0.05 | — | 0.03 | 0.05 | -0.04 | — | -0.06 |
| EPS (diluted) | 0.13 | -0.05 | — | 0.03 | 0.05 | -0.04 | — | -0.06 |
| Weighted avg. shares (diluted) | 290.50M | 283.68M | — | 288.22M | 285.74M | 277.55M | — | 274.50M |
| Balance sheet | ||||||||
| Cash & equivalents | $293.50M | $166.80M | $256.74M | $237.41M | $189.73M | $138.74M | $181.66M | $121.02M |
| Receivables | $38.39M | $36.93M | $45.81M | $42.90M | $34.52M | $36.08M | $40.42M | $40.43M |
| Inventory | $601.59M | $632.91M | $590.21M | $617.90M | $608.51M | $645.47M | $653.33M | $690.29M |
| Current assets | $1.05B | $960.84M | $1.02B | $1.01B | $939.56M | $920.43M | $973.62M | $931.78M |
| PP&E, net | $630.30M | $645.91M | $656.15M | $669.64M | $687.50M | $704.45M | $725.44M | $739.81M |
| Goodwill | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M | $980.06M |
| Total assets | $5.17B | $5.08B | $5.17B | $5.21B | $5.15B | $5.12B | $5.19B | $5.21B |
| Current liabilities | $1.17B | $1.13B | $1.13B | $1.10B | $1.06B | $1.08B | $1.14B | $1.11B |
| Short-term debt | $12.06M | $13.24M | $4.61M | $5.10M | $5.46M | $5.37M | $5.35M | $5.29M |
| Long-term debt | $590.57M | $590.15M | $0 | $1.58B | $1.58B | $1.58B | $1.58B | $1.58B |
| Total debt | $602.63M | $603.39M | $4.61M | $1.59B | $1.59B | $1.58B | $1.58B | $1.58B |
| Total liabilities | $3.96B | $3.93B | $4.01B | $4.05B | $4.01B | $4.01B | $4.08B | $4.09B |
| Shareholders' equity | $1.21B | $1.16B | $1.16B | $1.16B | $1.14B | $1.11B | $1.11B | $1.12B |
| Net debt | $309.13M | $436.59M | -$252.13M | $1.35B | $1.40B | $1.45B | $1.40B | $1.46B |
| Cash flow statement | ||||||||
| Operating cash flow | $161.55M | -$30.97M | $153.52M | $90.09M | $85.89M | -$15.45M | $95.99M | $20.72M |
| Capital expenditure | $31.64M | $38.15M | $37.14M | $29.44M | $32.10M | $28.41M | $36.95M | $31.01M |
| Free cash flow | $129.92M | -$69.12M | $116.39M | $60.65M | $53.79M | -$43.87M | $59.04M | -$10.29M |
| Investing cash flow | -$31.44M | -$37.85M | -$37.14M | -$29.33M | -$30.96M | -$27.13M | -$34.40M | -$31.44M |
| Financing cash flow | -$3.56M | -$32.64M | -$96.40M | -$1.07M | -$3.95M | -$334,000 | -$952,000 | -$1.91M |
| Depreciation & amortization | $50.40M | $49.04M | $48.24M | $49.82M | $49.36M | $49.81M | $50.31M | $50.11M |
| Stock-based compensation | $8.60M | $9.45M | $7.28M | $7.16M | $8.79M | $9.42M | $9.51M | $11.36M |
Free plan shows the latest 8 periods; Pro shows all 26 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.